AMPHADASE
NDC 0548-9090, hyaluronidase, injection, from Amphastar Pharmaceuticals, Inc..
- Product NDC
- 0548-9090
- Status
- Listed
- Labeler
- Amphastar Pharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA021665
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0548-9090 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYALURONIDASE150 [USP'U]/mL
Pharmacologic classes
Endoglycosidase [EPC]; Glycoside Hydrolases [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0548-9090-10 | 00548909010 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0548-9090-10) / 1 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8396ea96-7cb5-4e26-87a4-90bca9c3c6ddMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0548-9090
Use it
Look up 0548-9090 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0548-9090 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0548-9090. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.